Asthma and Respiratory Foundation NZ
Menu
Donate
Asthma and Respiratory Foundation NZ
In this section
Filter by topic:
All Asthma COPD Research Bronchiectasis Lung cancer Obstructive sleep apnoea Housing Smoking Management plans Other conditions Access to primary care Health literacy Poverty Health workforce Social determinants IPF Vaping COVID-19

Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing:

Simon Couillard, Rahul Shrimanker, Samuel Lemaire-Paquette, Gareth M Hynes, Catherine Borg, Clare Connolly, Samantha Jane Thulborn, Angela Moran, Sarah Poole, Sophie Morgan, Timothy Powell, Ian Pavord, Timothy Hinks

8 July, 2022

NZ Respiratory Research Review Issue 200

‘Breathing Fire’: Impact of Prolonged Bushfire Smoke Exposure in People with Severe Asthma:

Beyene et al.

16 June, 2022

NZ Respiratory Research Review Issue 200

Using a knowledge translation framework to identify health care professionals’ perceived barriers and enablers for personalised severe asthma care:

Eleanor C. Majellano,Vanessa L. Clark,Rebecca F. McLoughlin,Peter G. Gibson,Vanessa M. McDonald

7 June, 2022

NZ Respiratory Research Review Issue 200

Violence-related distress and lung function in two longitudinal studies of youth:

Kristina Gaietto, Yueh-Ying Han, Erick Forno, Leonard B. Bacharier, Wanda Phipatanakul, Theresa W. Guilbert, Michael D. Cabana, Kristie Ross, Joshua Blatter, Edna Acosta-Pérez, Gregory E. Miller, Rafael E. de la Hoz, Franziska J. Rosser, Sandy Durrani, Glorisa Canino, Stephen R. Wisniewski, Juan C. Celedón

12 May, 2022

NZ Respiratory Research Review Issue 200

Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study:

Eric D. Bateman, David B. Price, Hao-Chien Wang, Adel Khattab, Patricia Schonffeldt, Angelina Catanzariti, Ralf J.P. van der Valk, Maarten J.H.I. Beekman

5 May, 2022

NZ Respiratory Research Review Issue 200

Anti-IL5 mepolizumab minimally influences residual blood eosinophils in severe asthma:

Glenn Van Hulst, Joseph Jorssen, Nathalie Jacobs, Monique Henket, Renaud Louis, Florence Schleich, Fabrice Bureau, and Christophe J. Desmet

17 March, 2022

NZ Respiratory Research Review Issue 200

Azithromycin for Poorly Controlled Asthma in Children - A Randomized Controlled Trial:

Jagat Jeevan Ghimire, MD Kana Ram Jat, MD Jhuma Sankar, MD Rakesh Lodha, MD Venkat K. Iyer, MD Hitender Gautam, MD Seema Sood, MD S.K. Kabra, MD

21 February, 2022

NZ Respiratory Research Review Issue 200

Benralizumab Effectiveness in Severe Asthma Is Independent of Previous Biologic Use:

David J. Jackson, MRCP, PhD Hassan Burhan, MD Andrew Menzies-Gow, PhD Paul Pfeffer, PhD Alexandra Nanzer, PhD Esther Garcia Gil, MD Tamsin Morris, BSc Trung N. Tran, MD, PhD Ian Hirsch, PhD Sabada Dube, PhD

21 February, 2022

NZ Respiratory Research Review Issue 200

Air Pollutants and Asthma Hospitalization in the Medicaid Population:

Yaguang Wei, Xinye Qiu, Matthew Benjamin Sabath, Mahdieh Danesh Yazdi, Kanhua Yin, Longxiang Li, Adjani A. Peralta, Cuicui Wang, Petros Koutrakis, Antonella Zanobetti, Francesca Dominici, and Joel D. Schwartz

24 January, 2022

NZ Respiratory Research Review Issue 200

Perspectives of mild asthma patients on maintenance versus as-needed preventer treatment regimens: a qualitative study :

Julie Foster, Richard Beasley, Irene Braithwaite, Tim Harrison, Mark Holliday, Ian Pavord, Helen Reddel

21 January, 2022

NZ Respiratory Research Review Issue 194